Medicure Inc. (OTCMKTS:MCUJF – Get Free Report)’s stock price passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.99 and traded as high as $1.88. Medicure shares last traded at $1.88, with a volume of 4,900 shares.
Medicure Price Performance
The business’s fifty day moving average is $1.03 and its 200-day moving average is $0.89. The company has a debt-to-equity ratio of 0.02, a current ratio of 0.97 and a quick ratio of 0.64. The firm has a market cap of $19.73 million, a PE ratio of -3.71 and a beta of 1.15.
Medicure (OTCMKTS:MCUJF – Get Free Report) last posted its quarterly earnings data on Friday, August 14th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.05). Medicure had a negative net margin of 23.14% and a negative return on equity of 54.55%. The firm had revenue of $5.36 million during the quarter, compared to analysts’ expectations of $2.45 million.
Medicure Company Profile
Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.
Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.
Further Reading
- Five stocks we like better than Medicure
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
